Post-approval studies (Phase 4)UnknownNCT03412513
What this trial is testing
Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease
Who this might be right for
Overactive BladderParkinson Disease
Seoul National University Hospital 144